PHAT — Phathom Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $919.43m
- $1.34bn
- $55.25m
Annual cashflow statement for Phathom Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -129 | -144 | -198 | -202 | -334 |
| Depreciation | |||||
| Non-Cash Items | 7.34 | 22.2 | 31.1 | 52.4 | 35.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 51.7 | -27.3 | 19.5 | 11.1 | 30.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -69.7 | -148 | -147 | -138 | -267 |
| Capital Expenditures | -1.04 | -0.328 | -1.04 | -1.63 | -0.135 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -1.04 | -0.328 | -1.04 | -1.63 | -0.135 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 114 | 44.7 | 120 | 368 | 183 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 43.7 | -104 | -27.5 | 228 | -84.1 |